Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2026 Jul 13;17:1905826. doi: 10.3389/fimmu.2026.1905826

Correction: Unraveling the transcriptome-based network of Tfh cells in primary Sjogren syndrome: insights from a systems biology approach

Danyang Luo 1,2,†, Lei Li 3,†, Yi Yang 1,2,†, Yulin Ye 1,2, Jiawei Hu 1,2, Yuan Zong 1,2, Jiawen Zhao 1,2, Yiming Gao 1,2, Haimin Xu 3,*, Ning Li 1,2,*, Yinyin Xie 4,5,*, Liting Jiang 1,2,*
PMCID: PMC13403321  PMID: 42516374

There was a mistake in Table 1 and Table 2 as published. Due to copy-paste errors during data integration, several records were duplicated and some correct data was missing. The corrected Table 1 and Table 2 appears below.

Table 1.

Phenotypes of pSS and non-pSS patients compared according to 2016 ACR/EULAR diagnostic criteria.

Clinical characteristic pSS (n=106) Non-pSS (n=46)
Gender (Female) 93/106 37/46
Age 48.50 ± 12.19 52.48 ± 12.23
ANA+ (%) 91.5** 71.7
Anti-SSA+ (%) 87.7*** 26.1
Anti-Ro52+(%) 72.6** 45.7
Anti-SSB+ (%) 34.0*** 6.5
IgG (g/L) 18.21 ± 9.10*** 12.74 ± 3.79
IgA (g/L) 2.90 ± 1.30 2.68 ± 1.03
IgM (g/L) 1.50 ± 0.88 1.47 ± 0.82
C3 (g/L) 1.11 ± 0.23 1.13 ± 0.19
C4 (g/L) 0.27 ± 0.09 0.31 ± 0.12
Hypergammaglobulinaemia (%) 28.3** 10.9
Hypocomplementemia (%) 2.8 6.5

Data are mean ± standard deviation (SD) or n (%). *p<0.05; **p<0.01; ***p<0.001.

ANA, anti-nucleic antibody.

Table 2.

Clinical information for the 82 patients used for RNA sequencing grouped according to Tfh cell infiltration.

Clinical characteristic Tfh-high (n=34) Tfh-low (n=34)
Gender (Female) 29/34 25/34
Age 49.18 ± 13.26 49.68 ± 15.51
Xerostomia (%) 85.3** 52.9
Xerophthalmia (%) 61.8* 35.3
ANA+ (%) 94.1* 76.5
RF (%) 44.1** 8.8
Anti-SSA+ (%) 79.4 55.9
Anti-Ro52+(%) 58.8 52.9
Anti-SSB+ (%) 26.5 20.6
IgG (g/L) 17.43 ± 6.00** 13.30 ± 4.25
IgA (g/L) 3.01 ± 1.34 2.66 ± 1.08
IgM (g/L) 1.64 ± 1.04 1.41 ± 0.80
C3 (g/L) 1.08 ± 0.16 1.15 ± 0.22
C4 (g/L) 0.27 ± 0.09 0.32 ± 0.10
Hypergammaglobulinaemia (%) 44.1** 14.7
Hypocomplementemia (%) 2.9 2.9

Data are mean ± standard deviation (SD) or n (%). *p<0.05; **p<0.01; ***p<0.001. ANA= anti-nucleic antibody. RF, rheumatoid factors.

File Supplementary Table 1 and Supplementary Table 4 were erroneously published with the original version of this paper. The files have now been replaced.

The original version of this article has been updated.

Footnotes

Edited and reviewed by: Andreas Hutloff, University of Kiel, Germany

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES